Adrenomedullin is an Important Pathological Mediator in Progression of Chronic Neuropathic Pain.

BACKGROUND The characterization of neuropathic pain is maladaptive plasticity within the nociceptive system. Multiple alterations contribute to complex pain phenotypes. Adrenomedullin (AM) has been documented to be a pain mediator. However, its involvement in pathological pain is poorly understood. We studied the contribution of AM to chronic neuropathic pain in the spinal nerve ligation (SNL) model. METHODS Daily injection of the AM receptor antagonist AM22-52 (10 nmol) via an intrathecal (i.t.) route after SNL inhibited mechanical allodynia starting on day 6. Single administration of AM22-52 produced an immediate attenuation on pain hypersensitivity on day 2 or 10 post-SNL. Protein and mRNA levels were assayed by immunofluorescent staining and qRT-PCR, respectively, on days 1, 3, 7 and 15 post-SNL. RESULTS The results showed that AM at both protein and mRNA levels was increased in both injured (L5) and adjacent uninjured (L4) nerves starting on day 3 post-SNL. In dorsal root ganglion (DRG) at L5, AM was increase on days 1-7 at mRNA level but only on day 7 at protein level. However, AM was increase at mRNA level on days 1-7 and at protein level on days 3-15 in L4 DRG. AM mRNA expression was upregulated on days 1-7 in the spinal cord. Expression of receptor activity-modifying protein 2 (RAMP2), an essential AM1 receptor component, was upregulated in small and medium-diameter neurons on days 1-15 in both L5 and L4 DRG. Furthermore, single administration of AM22-52 suppressed the increase of nNOS in DRG induced by SNL and daily injection of AM22-52 for 7 days inhibited SNL-induced increase of CGRP mRNA in the spinal dorsal horn. CONCLUSIONS This study indicates that the increased AM bioactivity in injured and uninjured peripheral nerves, uninjured adjacent DRG and the spinal dorsal horn play a critical role mainly in the late-phase development of neuropathic pain. The mechanism may involve the recruitment of nNOS and CGRP.

[1]  S. M. Shafiee,et al.  Adrenomedullin increases cAMP accumulation and BDNF expression in rat DRG and spinal motor neurons , 2021, Iranian journal of basic medical sciences.

[2]  Cuk-Seong Kim,et al.  Arginase 2 Deficiency Promotes Neuroinflammation and Pain Behaviors Following Nerve Injury in Mice , 2020, Journal of clinical medicine.

[3]  A. Beitz,et al.  Astrocyte D-serine modulates the activation of neuronal NOS leading to the development of mechanical allodynia in peripheral neuropathy , 2019, Molecular pain.

[4]  Yan-guo Hong,et al.  Intrathecal administration of adrenomedullin induces mechanical allodynia and neurochemical changes in spinal cord and DRG , 2019, Neuroscience Letters.

[5]  V. Lemos,et al.  The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/KATP pathway: Role of eNOS and nNOS. , 2017, Nitric oxide : biology and chemistry.

[6]  Dongmei Wang,et al.  Adrenomedullin mediates tumor necrosis factor-α-induced responses in dorsal root ganglia in rats , 2016, Brain Research.

[7]  Dongmei Wang,et al.  Reversal of neurochemical alterations in the spinal dorsal horn and dorsal root ganglia by Mas-related gene (Mrg) receptors in a rat model of spinal nerve injury , 2016, Neurobiology of Disease.

[8]  Dongmei Wang,et al.  Mas-related gene (Mrg) C receptors inhibit mechanical allodynia and spinal microglia activation in the early phase of neuropathic pain in rats , 2016, Neuroscience Letters.

[9]  Y. Zhang,et al.  Involvement of adrenomedullin in spinal glial activation following chronic administration of morphine in rats , 2014, European journal of pain.

[10]  Qian Xu,et al.  Temporal changes in MrgC expression after spinal nerve injury , 2014, Neuroscience.

[11]  R. Quirion,et al.  Effect of Mas‐related gene (Mrg) receptors on hyperalgesia in rats with CFA‐induced inflammation via direct and indirect mechanisms , 2013, British journal of pharmacology.

[12]  Junying Wang,et al.  [Involvement of hippocampal NO/PKG signaling pathway in the accumulative analgesic effect of electroacupuncture stimulation of "Zusanli" (ST 36)-"Yanglingquan"(GB 34) in chronic neuropathic pain rats]. , 2013, Zhen ci yan jiu = Acupuncture research.

[13]  R. Quirion,et al.  Involvement of PKA-dependent upregulation of nNOS–CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats , 2013, Experimental Neurology.

[14]  A. Carrier-Ruiz,et al.  Bone marrow-derived fibroblast growth factor-2 induces glial cell proliferation in the regenerating peripheral nervous system , 2012, Molecular Neurodegeneration.

[15]  Yi Dai,et al.  Re-evaluation of the phenotypic changes in L4 dorsal root ganglion neurons after L5 spinal nerve ligation , 2012, PAIN.

[16]  J. Han,et al.  Upregulation of neuronal nitric oxide synthase in the periphery promotes pain hypersensitivity after peripheral nerve injury , 2011, Neuroscience.

[17]  R. Quirion,et al.  Blockade of adrenomedullin receptors reverses morphine tolerance and its neurochemical mechanisms , 2011, Behavioural Brain Research.

[18]  E. Romero-Sandoval,et al.  Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and μ opioid receptor protein expression while enhancing perivascular microglial ED2 , 2010, PAIN.

[19]  R. Quirion,et al.  Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats , 2009, PAIN.

[20]  Michael Costigan,et al.  Neuropathic pain: a maladaptive response of the nervous system to damage. , 2009, Annual review of neuroscience.

[21]  M. Jarvis,et al.  Neuropathic pain: models and mechanisms. , 2009, Current pharmaceutical design.

[22]  M. Al-Sultan,et al.  Unmyelinated primary afferents from adjacent spinal nerves intermingle in the spinal dorsal horn: A possible mechanism contributing to neuropathic pain , 2008, Brain Research.

[23]  Sung Min Kim,et al.  Local application of capsaicin alleviates mechanical hyperalgesia after spinal nerve transection , 2008, Neuroscience Letters.

[24]  Ping-Heng Tan,et al.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.

[25]  Tim Hucho,et al.  Signaling Pathways in Sensitization: Toward a Nociceptor Cell Biology , 2007, Neuron.

[26]  K. Sakimura,et al.  Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors. , 2007, Nitric oxide : biology and chemistry.

[27]  S. E. Lee,et al.  Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat , 2007, Neuroscience Research.

[28]  K. Park,et al.  The role of uninjured C-afferents and injured afferents in the generation of mechanical hypersensitivity after partial peripheral nerve injury in the rat , 2007, Experimental Neurology.

[29]  R. Quirion,et al.  A role for adrenomedullin as a pain-related peptide in the rat , 2006, Proceedings of the National Academy of Sciences.

[30]  M. Korostyński,et al.  Comparison of gene expression profiles in neuropathic and inflammatory pain. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[31]  M. L. Sotgiu,et al.  AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain , 2006, British journal of pharmacology.

[32]  D. Niv,et al.  Refractory Neuropathic Pain: The Nature and Extent of the Problem , 2006, Pain practice : the official journal of World Institute of Pain.

[33]  Ralf Baron,et al.  Mechanisms of Disease: neuropathic pain—a clinical perspective , 2006, Nature Clinical Practice Neurology.

[34]  Damir Sapunar,et al.  Distinct Membrane Effects of Spinal Nerve Ligation on Injured and Adjacent Dorsal Root Ganglion Neurons in Rats , 2005, Anesthesiology.

[35]  S. Maier,et al.  HIV-1 gp120 Stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS) , 2004, Pain.

[36]  M. Hamon,et al.  Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies , 2004, Pain.

[37]  D. Smith,et al.  CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8–37 and BIBN4096BS , 2003, British journal of pharmacology.

[38]  Patrick M. Sexton,et al.  International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors , 2002, Pharmacological Reviews.

[39]  James N. Campbell,et al.  Early Onset of Spontaneous Activity in Uninjured C-Fiber Nociceptors after Injury to Neighboring Nerve Fibers , 2001, The Journal of Neuroscience.

[40]  Jing Shan,et al.  Distribution of preproadrenomedullin mRNA in the rat central nervous system and its modulation by physiological stressors , 2001, The Journal of comparative neurology.

[41]  M. Devor,et al.  Spinal nerve injury enhances subthreshold membrane potential oscillations in DRG neurons: relation to neuropathic pain. , 2000, Journal of neurophysiology.

[42]  C. Hulsebosch,et al.  Alleviation of mechanical and thermal allodynia by CGRP8-37 in a rodent model of chronic central pain , 2000, Pain.

[43]  M. Santacana,et al.  Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy , 2000, Brain Research.

[44]  T. Fukuoka,et al.  Change in mRNAs for neuropeptides and the GABAA receptor in dorsal root ganglion neurons in a rat experimental neuropathic pain model , 1998, Pain.

[45]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[46]  D. Price,et al.  The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat , 1997, Pain.

[47]  K. Omote,et al.  Involvement of increased excitatory amino acids and intracellular Ca2+ concentration in the spinal dorsal horn in an animal model of neuropathic pain , 1996, Pain.

[48]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[49]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.